News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
681,738 Results
Type
Article (26862)
Company Profile (217)
Press Release (654911)
Multimedia
Podcasts (75)
Webinars (20)
Section
Business (220262)
Career Advice (1090)
Deals (33135)
Drug Delivery (85)
Drug Development (71829)
Employer Resources (88)
FDA (14855)
Job Trends (13037)
News (318923)
Policy (26904)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (6)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (6)
Academia (2040)
Accelerated approval (46)
ADA (37)
Adcomms (20)
Allergies (188)
Alliances (49141)
ALS (199)
Alzheimer's disease (1591)
Antibody-drug conjugate (ADC) (501)
Approvals (15517)
Artificial intelligence (808)
ASCO (266)
Autoimmune disease (333)
Automation (64)
Bankruptcy (317)
Best Places to Work (10542)
BIO (61)
Biologics (2)
BIOSECURE Act (10)
Biosimilars (176)
BioSpace Insights (125)
Biotechnology (145)
Bispecific (1)
Bladder cancer (204)
Brain cancer (67)
Breast cancer (797)
Cancer (6080)
Cardiovascular disease (474)
Career advice (949)
Career pathing (27)
CAR-T (348)
CDC (42)
CDMO (91)
Celiac Disease (2)
Cell therapy (932)
Cervical cancer (53)
Clinical research (64141)
Collaboration (2278)
Commercialization (8)
Company closure (2)
Compensation (1553)
Complete response letters (65)
COVID-19 (2057)
CRISPR (129)
C-suite (1275)
Cystic fibrosis (142)
Data (8544)
Decentralized trials (2)
Denatured (38)
Depression (154)
Dermatology (99)
Diabetes (581)
Diagnostics (7050)
Digital health (70)
Diversity (9)
Diversity, equity & inclusion (21)
Drug discovery (377)
Drug pricing (79)
Drug shortages (10)
Duchenne muscular dystrophy (274)
Earnings (87061)
Editorial (42)
Employer branding (9)
Employer resources (84)
Events (115102)
Executive appointments (1131)
FDA (18958)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (24)
Frontotemporal dementia (33)
Funding (1818)
Gene editing (262)
Generative AI (64)
Gene therapy (695)
GLP-1 (704)
Government (3037)
Grass and pollen (6)
Guidances (393)
Healthcare (16776)
Hematology (154)
HIV (84)
Huntington's disease (48)
IgA nephropathy (99)
Immunology and inflammation (203)
Immuno-oncology (94)
Indications (221)
Infectious disease (2399)
Inflammatory bowel disease (200)
Inflation Reduction Act (9)
Influenza (137)
Intellectual property (332)
Interviews (156)
IPO (15532)
IRA (22)
Job creations (2907)
Job search strategy (803)
JPM (29)
Kidney cancer (21)
Labor market (46)
Layoffs (261)
Leadership (32)
Legal (6672)
Licensing (16)
Liver cancer (88)
Longevity (36)
Lung cancer (797)
Lymphoma (440)
Machine learning (66)
Management (35)
Manufacturing (1104)
Marketing (13)
MASH (174)
Medical affairs (1)
Medical device (14246)
Medtech (14488)
Mergers & acquisitions (18984)
Metabolic disorders (1249)
mRNA (220)
Multiple sclerosis (171)
Multispecific (1)
NASH (15)
Neurodegenerative disease (420)
Neuropsychiatric disorders (80)
Neuroscience (3055)
NextGen: Class of 2026 (5673)
Non-profit (3360)
Now hiring (26)
Obesity (455)
Opinion (234)
Ovarian cancer (230)
Pain (255)
Pancreatic cancer (355)
Parkinson's disease (348)
Partnered (34)
Patents (651)
Patient recruitment (821)
Peanut (67)
People (56522)
Pharmaceutical (45)
Pharmacy benefit managers (18)
Phase 1 (20482)
Phase 2 (28303)
Phase 3 (20391)
Pipeline (10774)
Policy (201)
Postmarket research (2087)
Preclinical (8694)
Press Release (70)
Prostate cancer (320)
Psychedelics (26)
Radiopharmaceuticals (348)
Rare diseases (1032)
Real estate (5172)
Recruiting (39)
Regulatory (22552)
Reports (35)
Research institute (2026)
Resumes & cover letters (166)
Rett syndrome (49)
RNA editing (21)
RSV (78)
Schizophrenia (147)
Series A (309)
Series B (219)
Service/supplier (6)
Sickle cell disease (100)
Special edition (2)
Spinal muscular atrophy (142)
Sponsored (43)
Startups (3448)
State (2)
Stomach cancer (9)
Supply chain (97)
Tariffs (30)
The Weekly (34)
Vaccines (906)
Venture capital (81)
Weight loss (223)
Women's health (135)
Worklife (12)
Date
Today (152)
Last 7 days (473)
Last 30 days (2253)
Last 365 days (28148)
2026 (18954)
2025 (28068)
2024 (32758)
2023 (37397)
2022 (48103)
2021 (52047)
2020 (49852)
2019 (40930)
2018 (30642)
2017 (29188)
2016 (28301)
2015 (34695)
2014 (29089)
2013 (24785)
2012 (26791)
2011 (27149)
2010 (25898)
Location
Africa (555)
Alabama (98)
Alaska (6)
Arizona (402)
Arkansas (16)
Asia (35914)
Australia (5914)
California (14437)
Canada (4020)
China (1361)
Colorado (626)
Connecticut (601)
Delaware (372)
Europe (73692)
Florida (2209)
Georgia (490)
Hawaii (4)
Idaho (64)
Illinois (1145)
India (107)
Indiana (550)
Iowa (24)
Japan (625)
Kansas (142)
Kentucky (51)
Louisiana (59)
Maine (70)
Maryland (1658)
Massachusetts (10277)
Michigan (412)
Minnesota (800)
Mississippi (6)
Missouri (161)
Montana (33)
Nebraska (23)
Nevada (143)
New Hampshire (89)
New Jersey (3626)
New Mexico (33)
New York (3727)
North Carolina (1831)
North Dakota (10)
Northern California (7271)
Ohio (445)
Oklahoma (25)
Oregon (35)
Pennsylvania (2823)
Puerto Rico (27)
Rhode Island (52)
South America (846)
South Carolina (93)
South Dakota (2)
Southern California (5857)
Tennessee (241)
Texas (2430)
United States (50620)
Utah (450)
Vermont (2)
Virginia (282)
Washington D.C. (65)
Washington State (1179)
West Virginia (3)
Wisconsin (161)
Wyoming (2)
681,738 Results for "critical outcome technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
June 8, 2026
·
5 min read
Press Releases
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
August 27, 2026
·
8 min read
Press Releases
Battelle-Led Environmental Monitoring and Remediation Technology Assessment Initiative (EMRTAI) Opens Call for Applications for Technology Assessments for Critical Mineral Recovery
April 29, 2026
·
4 min read
Job Trends
Make or break: Commercial hires critical for success
With the stakes for successful launches high, and demand for commercial roles increasing, biopharmas must thoughtfully approach not only hiring but also retention. During a
BioSpace
webinar, experienced commercial leaders and a recruiter discussed the challenges employers face and how to tackle them.
July 23, 2026
·
3 min read
·
Angela Gabriel
Press Releases
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
August 18, 2026
·
7 min read
Press Releases
U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children
August 26, 2026
·
6 min read
Press Releases
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
December 17, 2025
·
5 min read
Press Releases
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
July 14, 2026
·
10 min read
Press Releases
BridgeBio Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
August 31, 2026
·
7 min read
Press Releases
Augurex Named ADLM 2026 Disruptive Technology Award Finalist
• Augurex’s SPINEstat® (Anti-14-3-3eta Multiplex for axial spondyloarthritis) test has been selected as a finalist in the ADLM 2026 Disruptive Technology Award, one of laboratory medicine’s most competitive recognition programs. • Augurex will present at ADLM 2026 on July 27 in Anaheim, CA, with a dedicated finalist kiosk on the Expo Floor July 28–30. • The recognition underscores Augurex’s leadership in developing biomarker-driven diagnostics that address critical unmet needs across autoimmune and inflammatory diseases.
May 28, 2026
·
1 min read
1 of 68,174
Next
